<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT934-12028</title>
	</head>
	<body>
		<main>
			<p>931028 FT  28 OCT 93 / UK Company News: Ethical Holdings Pounds 50,822 in the black Ethical Holdings, the Huntingdon-based pharmaceuticals group which is quoted on the Nasdaq market in the US, reported a net profit of Pounds 50,822 for the year to August 31, against a deficit of Pounds 76,342 last time. The improvement was achieved on revenues up from Pounds 7.16m to Pounds 9.49m. At the operating level income totalled Pounds 1.17m compared with a deficit of Pounds 430,196. During the fourth quarter the company signed seven new contracts for its products and completed a licensing agreement for a new transdermal product commissioned by a US company. In addition, two contracts for the licensing of Ethical's estradiol and combination norethisterone/estradiol transdermal patches in previously unlicensed territories were signed with a new partner. Mr Geoffrey Guy, chairman and chief executive officer, said the company had no immediate plans to float on the UK market, but was closely monitoring the performance of shares of its competitors that had taken this step.</p>
		</main>
</body></html>
            